• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基酸、柠檬酸钙和菊粉 Keto 类似物在慢性肾脏病管理中的适宜性:兰德/UCLA 共识。

Appropriateness of Ketoanalogues of Amino Acids, Calcium Citrate, and Inulin Supplementation for CKD Management: A RAND/UCLA Consensus.

机构信息

Centro Medico Dalinde, Mexico City 06760, Mexico.

Hospital Trinidad, Mexico City 06760, Mexico.

出版信息

Nutrients. 2024 Sep 2;16(17):2930. doi: 10.3390/nu16172930.

DOI:10.3390/nu16172930
PMID:39275246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11397001/
Abstract

BACKGROUND

Current treatment for chronic kidney disease (CKD) focuses on improving manifestations and delaying progression. Nutritional approaches play a crucial role in CKD management, and various supplements have become available. Ketoanalogues of amino acids (KAs), calcium citrate, and inulin have been proposed as suitable supplements, yet their widespread use has been limited due to insufficient evidence. This study aimed to generate general guidance statements on the appropriateness of these supplements through a RAND/UCLA consensus process.

METHODS

A RAND/UCLA consensus panel was convened to evaluate the appropriateness of these supplements in different clinical scenarios. In this study, we present a subgroup analysis focusing on a panel of eleven clinical nephrologists from among the experts.

RESULTS

Supplementation of low-protein diets (LPDs) and very low-protein diets (VLPDs) with KA was considered appropriate to reduce manifestations and delay CKD outcomes, supplementation with calcium citrate is considered appropriate to reduce CKD manifestations, and supplementation with inulin is considered appropriate to delay CKD outcomes and manage comorbidities.

CONCLUSIONS

Based on a combination of clinical experience and scientific evidence, the panel reached a consensus that KA supplementation of LPD and VLPD, calcium citrate, and inulin are appropriate in patients with CKD across various scenarios.

摘要

背景

目前,慢性肾脏病(CKD)的治疗重点在于改善表现并延缓进展。营养方法在 CKD 管理中起着至关重要的作用,各种补充剂也已面世。氨基酸的酮类似物(KAs)、柠檬酸钙和菊粉已被提议作为合适的补充剂,但由于证据不足,其广泛应用受到限制。本研究旨在通过 RAND/UCLA 共识过程生成关于这些补充剂适当性的一般指导陈述。

方法

召集了 RAND/UCLA 共识小组,以评估这些补充剂在不同临床情况下的适当性。在本研究中,我们展示了一项针对专家组中 11 名临床肾病学家的小组分析。

结果

用 KA 补充低蛋白饮食(LPD)和极低蛋白饮食(VLPD)被认为可适当减少 CKD 表现并延缓其结果,补充柠檬酸钙被认为可适当减少 CKD 表现,而补充菊粉被认为可适当延缓 CKD 结果并控制合并症。

结论

基于临床经验和科学证据的综合考虑,专家组达成共识,认为在各种情况下,KA 补充 LPD 和 VLPD、柠檬酸钙和菊粉均适用于 CKD 患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151f/11397001/8e962fd3aae8/nutrients-16-02930-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151f/11397001/ef979da358db/nutrients-16-02930-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151f/11397001/8e962fd3aae8/nutrients-16-02930-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151f/11397001/ef979da358db/nutrients-16-02930-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151f/11397001/8e962fd3aae8/nutrients-16-02930-g002.jpg

相似文献

1
Appropriateness of Ketoanalogues of Amino Acids, Calcium Citrate, and Inulin Supplementation for CKD Management: A RAND/UCLA Consensus.氨基酸、柠檬酸钙和菊粉 Keto 类似物在慢性肾脏病管理中的适宜性:兰德/UCLA 共识。
Nutrients. 2024 Sep 2;16(17):2930. doi: 10.3390/nu16172930.
2
Is there a role for ketoacid supplements in the management of CKD?在慢性肾脏病的治疗中,酮酸补充剂是否有作用?
Am J Kidney Dis. 2015 May;65(5):659-73. doi: 10.1053/j.ajkd.2014.09.029. Epub 2015 Feb 12.
3
A practical approach to low protein diets for patients with chronic kidney disease in Cameroon.喀麦隆慢性肾病患者低蛋白饮食的实用方法
BMC Nephrol. 2016 Sep 7;17(1):126. doi: 10.1186/s12882-016-0340-5.
4
Ketoacid Analogues Supplementation in Chronic Kidney Disease and Future Perspectives.酮酸类似物补充在慢性肾脏病中的应用及未来展望。
Nutrients. 2019 Sep 3;11(9):2071. doi: 10.3390/nu11092071.
5
Long-Term Effects of Ketoanalogues on Mortality and Renal Outcomes in Advanced Chronic Kidney Disease Patients Receiving a Low-Protein Diet.长期使用酮酸类似物对接受低蛋白饮食的晚期慢性肾脏病患者的死亡率和肾脏结局的影响。
Nutrients. 2020 Sep 4;12(9):2708. doi: 10.3390/nu12092708.
6
Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease.极低蛋白饮食可降低慢性肾脏病患者的硫酸吲哚酚水平。
Blood Purif. 2013;35(1-3):196-201. doi: 10.1159/000346628. Epub 2013 Mar 13.
7
Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease.低蛋白饮食和菊粉对慢性肾脏病患者肠道菌群和临床参数的影响。
Nutrients. 2019 Dec 9;11(12):3006. doi: 10.3390/nu11123006.
8
Dietary protein intake and chronic kidney disease.膳食蛋白质摄入量与慢性肾脏病
Curr Opin Clin Nutr Metab Care. 2017 Jan;20(1):77-85. doi: 10.1097/MCO.0000000000000342.
9
Muscle protein turnover and low-protein diets in patients with chronic kidney disease.慢性肾脏病患者的肌肉蛋白质周转率和低蛋白饮食。
Nephrol Dial Transplant. 2020 May 1;35(5):741-751. doi: 10.1093/ndt/gfaa072.
10
Short-term effects of a very-low-protein diet supplemented with ketoacids in nondialyzed chronic kidney disease patients.极低蛋白饮食补充酮酸对未透析慢性肾病患者的短期影响。
Eur J Clin Nutr. 2005 Jan;59(1):129-36. doi: 10.1038/sj.ejcn.1602050.

本文引用的文献

1
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.KDIGO 2024慢性肾脏病评估与管理临床实践指南
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
2
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.心血管-肾脏-代谢(CKM)综合征的科学证据和临床管理概要:美国心脏协会的科学声明
Circulation. 2023 Nov 14;148(20):1636-1664. doi: 10.1161/CIR.0000000000001186. Epub 2023 Oct 9.
3
Supplemented Very Low Protein Diet (sVLPD) in Patients with Advanced Chronic Renal Failure: Clinical and Economic Benefits.
补充极低蛋白饮食(sVLPD)治疗晚期慢性肾衰竭患者的临床和经济效益。
Nutrients. 2023 Aug 13;15(16):3568. doi: 10.3390/nu15163568.
4
Low-protein diet supplemented with inulin lowers protein-bound toxin levels in patients with stage 3b-5 chronic kidney disease: a randomized controlled study.低蛋白饮食联合菊粉补充可降低 3b-5 期慢性肾脏病患者的蛋白结合毒素水平:一项随机对照研究。
Nutr Hosp. 2023 Aug 28;40(4):819-828. doi: 10.20960/nh.04643.
5
Economic Analysis of a Ketoanalogue-supplemented Very Low-protein Diet in Patients With Chronic Kidney Disease in Vietnam.越南慢性肾脏病患者酮酸类似物补充极低蛋白饮食的经济学分析。
Clin Ther. 2023 Jul;45(7):649-654. doi: 10.1016/j.clinthera.2023.05.008. Epub 2023 Jun 24.
6
Development of quality indicators for the diagnosis and treatment of urinary tract infections in general practice: a RAND appropriateness method.基层医疗泌尿系感染诊断与治疗质量指标的制定:RAND 适宜性方法。
BMJ Open Qual. 2023 May;12(2). doi: 10.1136/bmjoq-2022-002156.
7
An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19.新冠疫情期间对兰德/加州大学洛杉矶分校改良德尔菲专家小组法的一种改编
J Healthc Leadersh. 2022 May 20;14:63-70. doi: 10.2147/JHL.S352500. eCollection 2022.
8
Epidemiology of chronic kidney disease: an update 2022.慢性肾脏病流行病学:2022年最新情况
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.
9
Link between gut microbiota dysbiosis and chronic kidney disease.肠道微生物失调与慢性肾脏病的关系。
Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2057-2074. doi: 10.26355/eurrev_202203_28354.
10
Effects of Probiotics, Prebiotics, and Synbiotics on Uremic Toxins, Inflammation, and Oxidative Stress in Hemodialysis Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.益生菌、益生元及合生元对血液透析患者尿毒症毒素、炎症和氧化应激的影响:一项随机对照试验的系统评价和荟萃分析
J Clin Med. 2021 Sep 28;10(19):4456. doi: 10.3390/jcm10194456.